Lifetime Excess Weight, Adult Weight Gain Linked to Increased Renal Cancer Risk
By Elana Gotkine HealthDay Reporter
MONDAY, March 24, 2025 -- Lifetime excess weight and adult weight gain are associated with an increased risk for renal cell carcinoma (RCC), according to a study published online March 24 in Cancer.
Zhengyi Deng, Ph.D., M.B.B.S., from the Stanford University School of Medicine in Palo Alto, California, and colleagues examined data on lifetime body mass index (BMI) patterns and their associations with RCC. Data for 204,364 participants from the National Institutes of Health-American Association of Retired Persons Diet and Health Study were used to assess BMI at ages 18 years, 25 years, 50 years, and baseline (mean age, 61.6 years); BMI trajectory across adulthood; exposure to excess weight (weighted years with overweight/obesity [WYO]); and change in BMI between specific ages.
The researchers found that with the exception of chromophobe RCC, higher BMI at all ages was associated with an increased risk for overall RCC and all subtypes (hazard ratio, 1.10 to 1.40 per 5-unit increase). Compared with maintaining normal BMI, similar patterns were seen for BMI trajectories indicating weight gain during adulthood to overweight/obesity. Increased risks for overall RCC, aggressive RCC, fatal RCC, and clear-cell RCC were seen in association with higher WYO (hazard ratios, 1.17, 1.21, 1.16, and 1.20, respectively, per standard deviation increase). A reduction of ≥10 percent in BMI after age 50 years was associated with a lower risk for RCC (hazard ratio, 0.72).
"These findings emphasize that maintaining a healthy weight across one's lifetime is important for reducing RCC risk," Deng said in a statement. "More importantly, weight loss, even later in life, may offer protective benefits."
Two authors disclosed ties to industry.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted March 2025
Read this next
Few Adolescents With Obesity Prescribed Obesity Medications
FRIDAY, June 13, 2025 -- Despite an increase in the prevalence of prescribing, only 0.5 percent of U.S. adolescents with obesity were prescribed an obesity medication in 2023...
Real-World Weight Loss With Semaglutide, Tirzepatide Less Than That Seen in Clinical Trials
THURSDAY, June 12, 2025 -- For patients with obesity initiating pharmacotherapy with semaglutide or tirzepatide, weight loss at one year is 8.7 percent on average, which is lower...
Adherence to Healthy Diet Improves Cardiometabolic Risk, Even Without Weight Loss
WEDNESDAY, June 11, 2025 -- A healthy diet improves cardiometabolic risk factors, even if not associated with weight loss (WL), according to a study published online June 5...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.